Replies to post #220959 on Avid Bioservices Inc (CDMO)

[JJ1223]

Possibly with a nudge from BP, MSK may have come knocking on the door in Tustin. I am convinced more news will follow shortly. GLTA
https://www.mskcc.org/blog/msk-shares-historic-gift-fund-immunotherapy-research

[stoneroad]

Hard to argue that Bavi and the PS Platform could be in better hands.

[biopharm]

I agree.... and find this "Immune Monitoring Facility" of interest:

More recently, Ludwig Cancer Research has supported a state-of-the-art Immune Monitoring Core Facility, which allows researchers to measure the impact of new immunologic therapies in patients enrolled in clinical trials at Memorial Sloan Kettering, as well as at collaborating sites all over the world.

“The increased support will not only allow us to expand our Immune Monitoring Facility, but will also permit us to catalyze the field by providing funding for novel clinical trials that seek to clinically exploit the most important scientific discoveries in the area of cancer immunology,” explains Jedd Wolchok, who serves as Associate Director of the Ludwig Center for Cancer Immunotherapy.